Evaluation of Patients' perceptions towards Jan Aushadhi Pariyojana in Mumbai and the Suburbs
Keywords:
N\AAbstract
The Indian pharmaceutical industry plays a crucial global role by providing affordable, high-quality generic medicines and vaccines, particularly through initiatives like the Pradhan Mantri Bhartiya Jan Aushadhi Pariyojana (PMBJP). This study investigates the awareness, accessibility, and acceptance of Jan Aushadhi Medicines among patients, exploring how well the PMBJP has addressed India's need for affordable healthcare. Using an exploratory, descriptive research design and informal interviews with a sample of Jan Aushadhi consumers and non-consumers, the study reveals that while general awareness of generic medicines is relatively high, knowledge of Jan Aushadhi products remains limited. Only 40% of respondents were aware of Jan Aushadhi Medicines, with fewer possessing a comprehensive understanding. Accessibility issues and stock shortages further challenge the program's impact, as does a strong doctor preference for prescribing branded medicines.
The findings highlight that increased visibility, targeted outreach, and enhanced availability of Jan Aushadhi Kendras could significantly improve access to affordable medications. Recommendations include expanding awareness campaigns, partnering with state-level hospitals, encouraging doctors to prescribe generics, and implementing effective inventory management to reduce stock shortages. By improving public confidence in Jan Aushadhi products and fostering a supportive ecosystem, the program can better meet its objective of reducing healthcare costs, particularly for economically disadvantaged populations. This study underscores the potential of Jan Aushadhi to make healthcare more affordable but calls for concerted efforts to overcome barriers to its widespread adoption
Downloads
Metrics
References
Kurup, R. (2023, April 5). India: The emerging pharmacy of the world. Asian Lite. Retrieved from https://asianlite.com/2023/health/india-the-emerging-pharmacy-of-the-world/ Asian Lite
Pharmaceuticals Export Promotion Council of India. (n.d.). Home. Retrieved May 10, 2025, from https://pharmexcil.com Pharmexcil
Jain, V. M. (2023, March 2). Generic drugs & its future in India. Times of India Blogs. Retrieved from https://timesofindia.indiatimes.com/blogs/voices/generic-drugs-its-future-in-india/ The Times of India
Ministry of Chemicals and Fertilizers, Government of India. (n.d.). Pradhan Mantri Bhartiya Janaushadhi Pariyojana. Retrieved May 10, 2025, from https://janaushadhi.gov.in
Krishna, A., Simon, P., Palatty, P. L., Sacheendran, D., Jayachandran, M., George, T., & Baliga, M. S. (2024). Cost analysis of anticancer chemotherapy and chemoirradiation regimens considering the drugs marketed through Jan Aushadhi (People’s Medicine) stores and their branded counterparts: First cost comparison study. Journal of Cancer Research and Therapeutics, 20, 1472-1485
Desai, S., Dass, A. P., & Kaniganti, S. (2018). Assessment of perception and attitude of postgraduates and clinicians toward generic versus branded medicines at a teaching medical institute. National Journal of Physiology, Pharmacy and Pharmacology, 8(4), 540-543. https://doi.org/10.5455/njppp.2018.8.1144523112017
Shabaraya, A. R., & Shetty, R. (2023). A review on the Janaushadhi Scheme: Transforming acquisition to affordable medicines in India. International Journal in Pharmaceutical Sciences, 1(12), 88–94. https://doi.org/10.5281/zenodo.10259580
Laing R, Waning B, Gray A, Ford N, t Hoen E. 25 years of the WHO essential medicines lists: progress and challenges. Lancet. 2003;361(9370):1723–1729. doi: 10.1016/S0140-6736(03)13375-2. - DOI - PubMed
Attridge CJ, Alexander SP. Improving access to medicines in developing countries. Washington, DC: The World Bank; 2005.
Alfonso-Cristancho, R., Andia, T., Barbosa, T., & Watanabe, J. H. (2015). Definition and classification of generic drugs across the world. Applied Health Economics and Health Policy, 13(Suppl 1), S5–S11. https://doi.org/10.1007/s40258-014-0146-1
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
